Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
InnovAge Holding Corp. operates as a provider of healthcare services, focusing on delivering comprehensive care to older adults through its PACE (Program of All-Inclusive Care for the Elderly) model. The company primarily serves markets in California and Colorado, leveraging its unique integrated care approach to differentiate itself in the rapidly growing senior care sector.
InnovAge generates revenue primarily through government reimbursements for its PACE services, which provide a full spectrum of healthcare, including medical, social, and rehabilitative services for elderly patients. The company's competitive advantage lies in its ability to deliver coordinated care, resulting in better health outcomes and reduced hospitalizations.
Changes in government reimbursement rates for PACE programs
Enrollment growth in PACE services, particularly in California and Colorado
Operational efficiency improvements leading to margin recovery
Regulatory changes impacting senior care funding
Regulatory changes in Medicare and Medicaid funding could impact reimbursement rates.
Technological disruption in healthcare delivery models could alter competitive dynamics.
Emerging competitors in the senior care space leveraging technology for better service delivery.
Established healthcare providers expanding into the PACE market.
Negative operating margins leading to potential liquidity concerns if not addressed.
Dependence on government funding, which could be subject to budget cuts.
moderate - The demand for healthcare services is generally stable, but economic downturns can affect government funding and consumer spending on ancillary services.
InnovAge's financing costs are relatively low due to its manageable debt levels, but rising interest rates could impact future expansion plans and overall valuation multiples.
minimal - The company has a low debt-to-equity ratio of 0.41, indicating limited reliance on external credit.
growth - Investors may be drawn to InnovAge's potential for expansion in the senior care market as the population ages.
moderate - The stock has shown significant price fluctuations, evidenced by a 46.2% return over six months followed by a 20.4% decline.